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Replication indexAbstract Background: Terminalia catappa has been used as a folk medicine for treating dermati-
tis, hepatitis as well as other diseases in India. It possesses anticancer, antioxidant as well as
anticlastogenic characteristics.
Aim: The aim of the present investigation is to highlight the anticarcinogenic and antimutagenic
potential of extracts of T. catappa.
Subjects: Anticarcinogenic potential of methanolic extract of T. catappa has been tested against
the carcinogenicity induced by methyl methanesulfonate in the in vitro and in vivo models.
Methods: The parameters for evaluation included chromosomal aberrations (CA), sister chroma-
tid exchanges (SCEs) and replication indices (RI) both in the presence as well as in the absence of
exogenous metabolic activation system (in vitro study) and total aberrant cells and the frequencies
of aberrations were used (for in vivo methods).
228 M.S. Ahmad et al.Results: Alcoholic extracts of T. catappa signiﬁcantly reduce chromosomal aberration from
34.42%, 70.65% and 82.80% at 24, 48, and 72 h produced by methyl methanesulfonate (MMS) to
22.77%, 49.60% and 42.50% levels. Similarly the number of sister chromatid exchanges was reduced
from 6.20 per cell to 3.10 per cell at 48 h of treatment and replication index was enhanced in vitro for
each concentration and duration of treatment. Further their ameliorating potential was dose and
duration dependant. Similarly these extracts signiﬁcantly reduced the number of aberrant cells or fre-
quency of aberrations per cell in vivo.
Conclusion: Extracts of T. catappa signiﬁcantly reduced chromosomal aberrations up to 11.65%
to 40.30% at different dosages against MMS induced toxicity, similarly sister chromatid exchange
was reduced and replication index enhanced in vitro. Similarly in the in vivo experiments, the effective
reduction in clastogeny ranges from 19.70% to 40.90%. Their reducing potential was time and dose
dependant.
 2014 Production and hosting by Elsevier B.V. on behalf of Ain Shams University.1. Introduction
Terminalia catappa is a native plant of India having smooth
gray bark and whorled branches that form its thick canopy.
It belongs to the family Combretaceae, and it is widely distrib-
uted in tropical and subtropical regions. The leaves of the
plant have been used as a folk medicine for treating several
diseases in India and in the Philippines. Leaves of T. catappa
possess anti-cancer, antioxidant as well as anti-clastogenic
characteristics and are used in the treatment of different types
of cancer, leprosy, eye problems and also for reducing travel
nausea, to get rid of intestinal parasites and to stop bleeding
during teeth extraction [1,2]. The leaves contain no ascorbic
acid and the contents of b-carotene, a-tocopherol and
total phenols were found to be 36.7–39.3, 0.94–1.06 and
167–198 mg/g dry weight for the green, yellow fallen and red
fallen leaves, respectively [3].
It had been shown in earlier study that the mitomycin C-
induced micronuclei in Chinese hamster ovary K1 (CHO-K1)
cells were signiﬁcantly suppressed when the cells were treated
simultaneously with the aqueous extract of T. catappa leaves
[19]. It also reduced 12-O-tetradecanoylphorbol-13-acetate
(TPA)-induced production of hydrogen peroxide in human
mononuclear leukocytes. These effects were attributed to its
ability to inhibit TPA induction of hydrogen peroxide forma-
tion and scavenging of free oxygen radicals [4]. Earlier we have
shown the antimutagenic and antigenotoxic effects of carote-
noids, ﬂavonoids, vitamins and certain plant extracts [5–8].
The aim of present investigation is to highlight the anticarcino-
genic and antimutagenic potential of extracts of T. catappa in
human lymphocytes culture in vitro and in bone marrow cells
of Albino mice in vivo.2. Materials and methods
The whole plants ofT. catappa were dried under shade at room
temperature. The shade dried plants were powdered; around
60 g of coarse powder was defatted with petroleum ether and
the contents were extracted exhaustively with 95% methanol
at 60 C. The extract was dried by a vacuum evaporator.
Methanolic extract of T. catappa was dissolved in dimethyl
sulfoxide (DMSO) to prepare different optimum concentra-
tions for studies as shown in Tables A and B.2.1. Table of chemical concentration
(A) Control
Positive and negative control Concentrations
MMS 5 lg/ml
DMSO 5 lg/ml(B) In vivo concentrations of phyto-chemicals
Phytoproducts 1st Dose
ATE1
2nd
Dose
ATE2
3rd
Dose
ATE3
4th
Dose
ATE4
5th
Dose
ATE5
Alcoholic extracts of
Terminalia catappa
(in vivo mg/kg.bw)
200 250 300 350 400
Alcoholic extracts of
Terminalia catappa
(in vitro lg/ml)
50 100 150 200 NilMMS; methyl methanesulfonate, DMSO; dimethyl sulfox-
ide, ATE1 to ATE5; concentrations of alcoholic extracts of
T. catappa.
2.2. In vivo study
Thework is carried out in accordancewith the ‘TheCode of Eth-
ics of TheWorldMedical Association’ (Declaration ofHelsinki)
for Experiments involving humans and animals. Albino mice 8–
10 weeks old (25–35 g in weight) were exposed to different test
chemicals by appropriate routes (intra peritoneal i.e., I.P. injec-
tion) and were sacriﬁced at sequential intervals of 16, 24, and
32 h of stipulated treatment time. Animals were treated with
each test substance as mentioned above. Further processes of
slide preparations, cells and chromosomal aberration analyses
are adopted from earlier published work [9].
The reduction factors due to test chemical treatments were
calculated using the formula published earlier [10].
2.3. In vitro lymphocytes culture method
The chromosomal changes (numerical and structural) were uti-
lized for investigation of the genotoxic as well as antigenotoxic
Figure 1 Showing percentage reduction in aberrant cell due to
the effect of alcoholic extract of Terminalia catappa at 16, 24 and
32 h of treatment in the bone marrow cells of Albino mice
(p< 0.05).
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chromosomal aberrations (CA), sister chromatid exchanges
(SCEs) and cell growth kinetics (RI) both in the presence
and in the absence of exogenous metabolic activation system.
The in vitro culture methods, preparation of S9 (microsomal
fraction), media preparation and analyses of chromosomal
aberrations, sister chromatid exchanges, cell cycle kinetics
and statistical analysis were followed as per methodology pub-
lished earlier [9,10].
3. Results
3.1. In vivo effects
In the present study, the Albino mice were exposed to 16 h of
treatments with various doses of alcoholic extracts of Termina-
lia and methyl methanesulfonate simultaneously and it was
observed that the percentage of aberrant cells was 10.6%,
9.6%, 8.9%, 8.2% and 7.8%, respectively at ﬁve different con-
centrations of alcoholic extracts of T. catappa against the level
of 13.2% of aberrant cells induced by methyl methane sulfo-
nate (MMS) alone as positive control. While fragment types
of aberrations were most prominent followed by breaks and
gaps, exchanges were almost negligible. In terms of percentage
reduction in the frequencies of aberrant cells, the observed val-
ues are 19.70%, 27.27%, 32.57%, 37.87% and 40.90%, respec-
tively against ﬁve different concentrations of alcoholic extracts
of T. catappa. The maximum effect of T. catappa was 41.87%
at the 5th concentration of the extract (Table 1 Fig 1).
The effect on the total number of frequencies per thousand
cells was 181, 158, 145, 130 and 117 at ﬁve consecutive concen-
trations of alcoholic extracts ofT. catappa against the count of
237 when treated with MMS alone. The normal values were 25
for distilled water treatment and 28 and 28 for DMSO and
alcoholic extracts of T. catappa treatment alone (Table 2).
When treatment durations were increased to 24 h, the effects
of Terminalia extracts still followed the same trends of anti-
genotoxicity with increased value. These values were 12.0%,
11.2%, 10.1%, 9.4% and 8.3%, respectively for ﬁve concentra-
tions of alcoholic extracts of T. catappa against 13.5% of
MMS treatment only. Normal values were 2.3%, 2.5% andTable 1 Effect of alcoholic extracts of Terminalia catappa on the fre
methanesulfonate (MMS x/kg.bw) at 16 h of treatment.
Treatment Termin
(Y/Kg.bw)
Cell with
pulverized chromosome
Types of chrom
Gaps Breaks
DH2O 0 00 03 02
DMSO 0 00 01 03
MMS 0 15 37 35
ATE ATE5 00 04 03
MMS+ ATE ATE1 12 35 36
ATE2 10 32 33
ATE3 9 31 31
ATE4 8 27 30
ATE5 6 22 32
Note: ATE1 to ATE5; concentrations of alcoholic extracts of Terminalia
MMS; methyl methanesulfonate 5 lg/ml/kg body weight) at 16 h of treatm
Y/Kg.bw is the concentration of alcoholic extracts of Terminalia catappa
* Signiﬁcant at <0.05 probability.2.5%, respectively for pure water, DMSO and Terminalia
extracts alone respectively. The 5th dose of the extract remark-
ably reduced the percentage of aberrant cells (Fig 1). The total
aberrations per thousand cells were 223, 171, 160, 140 and 125
aberrations for extracts of T. catappa and MMS, against 286
aberrations due to MMS alone used as positive control. At
32 h of exposure, the percent of aberrant cells observed was
15.0% for MMS alone, and 11.5%, 10.5%, 9.5%, 8.9% and
8.0% for ﬁve different concentrations of alcoholic extracts of
T. catappa plus MMS, whereas the values for normal control
was 3.1%. However for DMSO and alcoholic extracts of T.
catappa alone, the levels were 3.0% and 3.2%, respectively.
In terms of the effects on the percent reduction in aberrant
cells, the range varied from 11.53% to 38.46%. These values
show signiﬁcant effect of the alcoholic extracts of T. catappa
on the number and percentage of aberrant cells. It also shows
almost dose-dependent relationship. More chromosomal
exchange types of aberrations were seen in contrast to the
previous two durations of treatment (Fig 1).quency of cells with chromosomal aberrations induced by methyl
atic aberrations Aberrant cell No. (%) (%) Reduction
Fragments Exchange
21 00 23 (2.3)
26 00 29 (2.9)
79 03 132 (13.2)
23 00 26 (2.6)
55 03 106 (10.6) 19.70
51 02 96 (9.6) 27.27*
47 02 89 (8.9) 32.57*
43 01 82 (8.2) 37.87*
40 00 78 (7.8) 40.90*
catappa, DH2O; double distilled water, DMSO; dimethyl sulfoxide,
ent. Calculations were made excluding the gap type of aberration and
.
Table 3 Analysis of chromosomal aberrations after treatment with methyl methanesulfonate along with alcoholic extracts of
Terminalia catappa in vitro in the presence of S9 mix.
Treatments Durations (h) Metaphase scored Percent aberration metaphase Aberration/Cell ± SE Aberration/Cell ± SE
Including gap Excluding gap Chromatid Chromosome Total
MMS 24 200 35.35 29.69 26.52 7.90 34.42 0.34 ± 0.03
48 200 32.75 30.15 47.85 22.80 70.65 0.71 ± 0.05
72 200 33.35 28.75 53.50 29.30 82.80 0.83 ± 0.08
MMS+ ATE1 24 200 32.32 27.35 24.50 7.72 32.22 0.32 ± 0.04
48 200 31.45 29.76 44.00 20.00 64.00 0.64 ± 0.06
72 200 23.35 21.00 48.30 27.20 75.50 0.76 ± 0.09
MMS+ ATE2 24 200 22.50 20.75 23.00 8.30 31.30 0.31 ± 0.03
48 200 30.15 28.89 42.40 18.30 60.70 0.61 ± 0.06
72 200 22.00 20.37 45.22 21.45 66.67 0.68 ± 0.08
MMS+ ATE3 24 200 18.45 17.35 21.54 5.38 26.92 0.27 ± 0.04
48 200 27.50 26.50 38.90 18.45 57.35 0.57 ± 0.05
72 200 20.35 19.25 43.32 21.00 64.32 0.64 ± 0.09
MMS+ ATE4 24 200 16.75 15.45 17.00 5.77 22.77 0.23 ± 0.03
48 200 24.35 23.22 35.00 14.60 49.60 0.50 ± 0.06
72 200 19.75 18.15 40.00 21.50 61.50 0.62 ± 0.06
Control
Normal 72 200 5.00 2.30 1.50 1.75 3.25 0.03 ± 0.02
DMSO+ ATE2 72 200 4.25 3.30 2.00 1.50 3.50 0.04 ± 0.02
Note: SE; standard error, ATE1 to ATE4; concentrations of alcoholic extracts of Terminalia catappa, DH2O; double distilled water, DMSO;
dimethyl sulfoxide, MMS; methyl methane sulfonate 5 lg/ml culture. Calculations were made excluding the gap type of aberration and
signiﬁcant at <0.05 probability level.
Table 2 Effect of alcoholic extracts of Terminalia catappa on the total number and types of frequency of cells with chromosome
aberrations induced by MMS (MMS x/kg.bw).
Treatment ATE (Y/Kg.bw) Cell with aberration Cell with aberration
0 1 2 3 4 5 6–9
DH2O 0 977 21 02 00 00 00 00 25
DMSO 0 971 26 03 00 00 00 00 32
MMS 0 868 86 21 09 06 05 05 237
ATE ATE5 974 24 02 00 00 00 00 28
MMS+ ATE ATE1 894 69 20 07 04 04 02 181
*
ATE2 904 65 18 05 03 03 02 158
*
ATE3 911 61 17 04 02 03 02 145
*
ATE4 918 60 19 05 03 03 02 130
*
ATE5 922 60 19 03 03 02 01 117
*
Note: ATE1 to ATE5; concentrations of alcoholic extracts of Terminalia catappa, DH2O; double distilled water, DMSO; dimethyl sulfoxide,
MMS; methyl methanesulfonate 5 lg/ml/kg.bw) at 16 h of treatment. Calculations were made excluding the gaps type of aberration and the
animals were sacriﬁced 16 h after MMS treatment 1000 cells from 10 animals were analyzed for each point. Y/Kg.bw is the concentration of
alcoholic extracts of Terminalia catappa.
* Signiﬁcant at <0.05 probability.
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cells recorded were 246 for MMS and about 195, 176, 165,
143 and 130 for alcoholic extracts of T. catappa along with
MMS alone for ﬁve different concentrations of the extracts.
These frequencies show the effects of the extracts ofT. catappa
in reducing signiﬁcantly the total aberrations as well as aberra-
tions per cell.
3.2. In vitro effects
The treatment with methyl methane sulfonate (MMS) results
in clastogenic abnormalities as observed in percent metaphaseaberration, types of aberrations and aberration per 100 cells
(34.42%, 70.65% and 82.80%), or being 0.34, 0.71 and 0.83
aberration per cell. For the DMSO plus T. catappa (ATE),
the values are 0.03, 0.04 per cell at single standard dosage
durations. At 24, 48 and 72 h. alcoholic extracts of T. catappa
bring down these aberrations from 34.42% to 32.22%,
31.30%, 26.92% and 22.77% with four consecutive dosages
at 24 h of duration, whereas at 48 h, it brings down the level
from 70.65% to 64.00%, 60.70%, 57.35% and 49.60%, done
by 1st to 4th concentrations of alcoholic extracts ofT. catappa.
The same trend was noticed, when the treatment duration was
increased to 72 h. These values show linear increasing trend
Figure 2 Expressing the antigenotoxic effect of alcoholic extract
of Terminalia catappa on chromosomal aberration in the absence
of S9 metabolic activation system in vitro (p< 0.05).
Figure 3 Expressing the antigenotoxic effect of alcoholic extract
of Terminalia catappa on chromosomal aberration in the presence
of S9 metabolic activation system in vitro (p< 0.05).
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mum percentage reductions in the aberrations were produced
by highest doses of alcoholic extracts of T. catappa (Table 3
Fig 2). When the culture was setup along with metabolicTable 4 Analysis of sister chromatid exchange after treatment w
Terminalia catappa in vitro, in the presence of +S9 mix.
Treatment Duration (h) Metaphase scored
MMS 48 50
MMS+ ATE1 48 50
MMS+ ATE2 48 50
MMS+ ATE3 48 50
MMS+ ATE4 48 50
Control
Normal 48 50
DMSO 48 50
DMSO+ATE2 48 50
Note: SE; standard error, ATE1 to ATE4; concentrations of alcoholic ex
dimethyl sulfoxide, MMS; methyl methane sulfonate 5 lg/ml/ culture. Caactivation system (+S9 mix) the action of MMS showed fur-
ther increase. The effect of the extracts of T. catappa also
shows similar trend; they lower the clastogenic activity of
MMS. These values show a linear increase with an increase
in doses (Fig 3). The highest reduction on clastogeny of cells
was noticed at 48 h durations; the other values are also statis-
tically signiﬁcant.
Sister chromatid exchange counts (Table 4) showed that the
reduction is evident both in the absence as well as in the pres-
ence of metabolic activation system; there being a lowering
trend of the mean range and the total SCEs and SCE per cell
respectively from 6.30 to 4.20 and from 6.20 to 3.10. For the
analysis of SCE, single treatment duration of 48 h of cultures
was used and 50 metaphases were scanned.
The effect of alcoholic extracts of T. catappa on replication
index (Table 5) shows an elevated level when compared with
the MMS treatment i.e. from 1.40 to 1.66 though lower than
the normal level of 1.79. The effect, after treatment with met-
abolic activation system, varied from 1.38 to 1.62, i.e., much
effective than without metabolic activation system. Therefore
alcoholic extracts of T. catappa clearly shows anticlastogenic
activities using CA, SCE and RI assays.
4. Discussion
Excess generation of ROS can cause oxidative damage to bio-
molecules resulting in lipid peroxidation, mutagenesis and car-
cinogenesis [11]. The herbal products are used worldwide in the
prevention and treatment of various chronic diseases, and their
potential anticancer and antimutagenic effects are under
current investigation. T. catappa leaf extracts exert a range of
biological effects on cells, including antioxidant and hepatopro-
tective activity on hepatocytes and liver mitochondria, and pre-
ventive activity against hepatocyte apoptosis [12]. Studies have
also suggested that its protective effects might be related to the
scavenging of reactive oxygen species (ROS) [13]. The increased
synthesis of very low density lipoprotein-cholesterol observed in
ﬁbrosarcoma-bearing control could have led to the increased
triglyceride levels in ﬁbrosarcoma-bearing animals. Finally,
excessive lipid peroxides formed in ﬁbrosarcoma condition
may lead to hyper-lipidemia [14]. Excessive rates of lipid perox-
idation may be root of the hyperlipidemia, found in many can-
cer patients [15]. The treatment of T. catappa signiﬁcantly
attenuated the alterations of lipid levels in tissue as well as in
serum. The normalization of lipid level in liver and kidneyith methyl methanesulfonate along with alcoholic extracts of
Total Range SCE /Cell ± SE
310 1–11 6.20 ± 1.50
290 1–10 5.80 ± 1.50
265 1–10 5.30 ± 1.50
185 1–9 3.70 ± 1.50
155 1–11 3.10 ± 1.50
95 0–5 1.90 ± 1.00
94 0–5 1.88 ± 1.00
97 0–5 1.94 ± 1.00
tracts of Terminalia catappa, DH2O; double distilled water, DMSO;
lculations were signiﬁcant at <0.05 probability level.
Table 5 Analysis of cell cycle kinetics after treatment with methyl methanesulfonate along with alcoholic extracts of Terminalia
catappa, in vitro, in the absence of S9 mix.
Treatment Cell scored (%) Cell in Replication index 2 · 3 Chi square test
M1 M2 M3
MMS 200 65 30 05 1.40
MMS+ ATE1 200 57 36 07 1.58 Signiﬁcant
MMS+ ATE2 200 50 40 10 1.60 ,,,,
MMS+ ATE3 200 49 39 12 1.63 ,,,,
MMS+ ATE4 200 47 40 13 1.66 ,,,,
Control
Normal 200 37 47 16 1.79
DMSO 200 38 45 17 1.79
DMSO+ ATE 2 200 40 43 17 1.77
Note: 2 · 3 Chi square (v2) test, ATE1 to ATE4; concentrations of alcoholic extracts of Terminalia catappa, DH2O; double distilled water,
DMSO; dimethyl sulfoxide, MMS; methyl methane sulfonate 5 lg/ml/culture. Calculations were signiﬁcant at <0.05 probability level.
232 M.S. Ahmad et al.tissues and serum upon T. catappa treatment may be due to an
enhanced lipogenesis or due to decrease in lipolysis, or both. It
indicates that alcoholic extract of T. catappa exhibited signiﬁ-
cant reversal of altered lipid levels near to normal values in rats
with experimentally-induced, ﬁbrosarcoma [16]. It also showed
anti-inﬂammatory activity in acute and chronic mouse models
of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced ear
edema [17]. Pretreatment with the Terminalia extract also abol-
ished the increase in caspase 3 activity and DNA fragmentation
that were observed in the livers of GalN/LPS-treated rats. Free
radical formation, speciﬁcally hydroxyl and singlet oxygen was
seen in GalN/LPS-treated rat liver, these were abolished by pre-
treatment with the Terminalia extract [12].
The ability of the water extract of T. catappa to prevent
metastasis was investigated under in vitro condition, using
A549 cell line. The water extract (0–100 lg/mL) did not affect
the viability of A549 cells although it was cytotoxic to LLC
(Lewis lung carcinoma) cells in a concentration-dependent
manner (IC50 of 14.5 lg/mL). The invasion and motility of
A549 cells was signiﬁcantly reduced using the aqueous extract
(50-100 lg/mL) in concentration-dependent manner. After
24 h, the extract (100 lg/ml) leaves behind only 24.8% and
28.8% of remaining cells, for cell invasion and motility, respec-
tively. Under in vivo condition, the water extracts decreased
lung metastases of LLC-bearing C57BL/6 mice by 68% com-
pared to controls. After 30 days of treatment with the water
extract, there was a 2.6-fold reduction in small solid tumors
in tumor-bearing mice as compared to controls. At this time,
the tumor weight was reduced by 2.3-fold and there was no
apparent signs of toxicity as indicated by body weight moni-
toring [18]. These results indicate that the aqueous extract of
T. catappa is a potentially important agent for the prevention
of lung cancer metastasis [18]. Similarly, CHO-K1 cells were
also protected against bleomycin-induced DNA-strand breaks,
measured by the comet assay, when the cells were pretreated
with the extract (75 and 100 lg/mL, respectively) for 24 h
before exposure to bleomycin (15 mU/ml) for 2 h which is par-
allel to our ﬁnding. These concentrations of the extract were
non toxic to CHO-K1 cells as cellular viability was not affected
by maximum concentrations of 100 lg/mL of the extract
for 24 h. The strong anti-genotoxic effect of the extract was
attributed to their ability to ameliorate bleomycin-induced
reactive oxygen species formation which was responsible forbleomycin’s DNA-damaging effect. The extract suppressed
the intracellular formation of superoxides and hydrogen per-
oxides by bleomycin, probably through direct scavenging of
superoxide anions and H2O2 [19]. Earlier it was noticed that
the aqueous extract of T. catappa suppressed the growth of
H-ras-transformed NIH3T3 cells in a concentration-dependent
manner. Cellular growth was completely suppressed by 100 lg/
mL of the water extract although in non-transformed NIH3T3
cells, this concentration only produced 30% cell death [20].
The hot water extract of T. catappa showed potent short-
term chemopreventive action on biomarkers of colon carcino-
genesis. Colon cancer was induced in 6 weeks old male F344
rats by weekly subcutaneous (s.c.) injections of azoxymethane
(20 mg/kg body weight) for 2 weeks. Aberrant crypt foci are
well known as visible preneoplastic lesions that develop in
the colonic mucosa of rats treated with azoxymethane, which
is a useful biomarker for colon carcinogenesis. T. catappa also
signiﬁcantly reduces cell proliferation activity of colonic muco-
sal epithelium as the proliferating cell nuclear antigen index
was lower than that of the control. The protection afforded
by T. catappa against colon carcinogenesis, therefore, was pos-
tulated to be related to its antioxidant activity [21].
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